Steriscience Specialties Profile
Key Indicators
- Authorised Capital ₹ 5.50 M
as on 09-07-2024
- Paid Up Capital ₹ 0.19 M
as on 09-07-2024
- Company Age 4 Year, 3 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 483.00 Cr
as on 09-07-2024
About Steriscience Specialties
The Corporate was formerly known as Steriscience Pharma Private Limited. The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 5.50 M and a paid-up capital of Rs 0.19 M.
The company currently has active open charges totaling ₹483.00 Cr.
The Key Managerial Personnel (KMP) at Steriscience Specialties Private Limited India is Neeraj Sharma as CEO. Aditya Kumar, Mahadevan Narayanamoni, Chandrappa Seetharamaiah, and Three other members serve as directors at the Company.
- CIN/LLPIN
U24304MH2020PTC424881
- Company No.
137884
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
29 Aug 2020
- Date of AGM
19 Jul 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Company Details
- Location
Thane, Maharashtra, India
- Telephone
- Email Address
- Website
- Social Media-
Who are the key members and board of directors at Steriscience Specialties?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Neeraj Sharma  | CEO | 22-Nov-2021 | Current |
Board Members(6)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Neeraj Sharma | Director and Ceo | 30-Sep-2022 | Current |
| Mahadevan Narayanamoni | Director | 03-May-2021 | Current |
| Aditya Kumar | Director | 27-Jan-2021 | Current |
| Chandrappa Seetharamaiah | Director | 02-Jun-2021 | Current |
| Bhushan Bopardikar | Additional Director | 13-Jun-2024 | Current |
| Chhitiz Saraogi | Additional Director | 13-Jun-2024 | Current |
Financial Performance of Steriscience Specialties.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
What is the Ownership and Shareholding Structure of Steriscience Specialties?
Unlock access to Steriscience Specialties's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
Skanray Healthcare Global Private LimitedActive 11 years 8 monthsChandrappa Seetharamaiah is a mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 23 Jan 2024 | ₹25.00 Cr | Open |
Others Creation Date: 28 Dec 2023 | ₹50.00 Cr | Open |
Yes Bank Limited Creation Date: 20 Jul 2023 | ₹50.00 Cr | Open |
How Many Employees Work at Steriscience Specialties?
Unlock and access historical data on people associated with Steriscience Specialties, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Steriscience Specialties, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Steriscience Specialties's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
